News of biotech VC's demise may be premature

05/16/2013 | Genetic Engineering & Biotechnology News

While venture capital investment in biotech has declined overall, investment in early-stage biosensor companies rose 152% and investment in biotech research rose 37% year-on-year during the first quarter of 2013, according to PricewaterhouseCoopers.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC